Jenny Rooke work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Jenny Rooke personal email
- Valid
Jenny Rooke phone numbers
I'm an investor & start-up utility player (C*, VP, BD) with a PhD in Genetics, a Bachelors in physics, and a background in computer science. I fund & build companies that change the way science gets done with new tools and technologies. I work closely with early-stage life science start-ups on issues of fundraising, market & product strategy, and business development. I love working with teams of brilliant scientists and engineers to transition great ideas and technologies into great products and companies. Keywords: genetics, DNA, synthetic biology, research tools, venture capital, capital formation, business development, strategy, life science technology.
-
Managing DirectorGenoa VenturesSan Francisco, Ca, Us
-
Investor, Board ObserverFellow Dec 2023 - PresentSan Francisco, California, Us -
Investor, DirectorBrightspec, Inc. Dec 2022 - PresentCharlottesville, Va, Us -
Investor, Board ObserverGeneral Inception Dec 2022 - PresentSan Francisco, California , Us -
InvestorRedux Bio Nov 2021 - PresentSan Francisco, Ca, Us -
Investor, DirectorStemson Therapeutics Jun 2021 - PresentSan Diego, California, Us -
Investor, DirectorMeiogenix Jun 2021 - PresentParis, Ile De France, Fr -
Investor, DirectorAqtual, Inc. Apr 2021 - PresentHayward, Ca, Us -
InvestorTropic Apr 2020 - PresentNorwich, Norfolk, Gb -
Member Board Of TrusteesThe Jackson Laboratory Feb 2019 - PresentBar Harbor, Me, Us -
Investor, Chair Of The BoardIntervenn Biosciences Oct 2018 - PresentSouth San Francisco, California, Us -
Managing DirectorGenoa Ventures 2012 - PresentSan Francisco, Ca, UsGenoa Ventures (formerly 5 Prime Ventures) invests in early-stage companies innovating at the intersection of biology and technology, with a focus on opportunities in research tools, molecular diagnostics, synthetic biology, ag biotech, and industrial biology.
-
AdvisorBill & Melinda Gates Foundation Nov 2016 - PresentSeattle, Wa, UsAdvisor and external network partner to BMGF Program Related Investments (PRI) team -
InvestorIonpath Inc. Oct 2015 - PresentMenlo Park, California, Us -
InvestorZymergen, Inc. Mar 2014 - Oct 2022Emeryville, California, UsInvestor from first round through 2022 IPO and acquisition by Ginkgo (DNA) -
Investor, DirectorIntabio Jun 2017 - Dec 2020Led Intabio's 2017 Seed round. Board director through company's successful exit to Sciex / Danaher in 2020.To read the story from the founder's perspective, see https://www.genoavc.com/genoa-news/crunchbase-news-interview
-
AdvisorCaribou Biosciences Sep 2016 - Dec 2020Berkeley, Ca, Us -
Board Of DirectorsCaribou Biosciences 2014 - Sep 2016Berkeley, Ca, UsCaribou Biosciences is developing a platform to enable engineering of any genome, at any site, in any way. The Caribou technology platform centers around CRISPR-derived protein Cas9. Cas9 is a programmable nuclease that uses short RNA molecules, known as guide RNAs, to target the protein to a specific sequence within double-stranded DNA. By changing the sequence of the guide RNA, Cas9 can be re-directed to almost any DNA sequence.
-
Board MemberKauffman Fellows Jun 2009 - Aug 2020Palo Alto, Ca, Us -
Venture PartnerF-Prime Capital Partners Oct 2013 - Dec 2017Cambridge, Ma, UsWith over $1B under management, F-Prime Capital (formerly known as Fidelity Biosciences) invests venture capital in private biopharmaceutical, medical technology, and healthcare IT and services companies. -
Venture PartnerAnterra Capital Mar 2016 - Nov 2017Amsterdam, Nl -
Board Of DirectorsCytek Biosciences Jun 2015 - Dec 2016Cytek Biosciences stands for excellence and innovation in Flow Cytometry. Cytek's engineers, scientists and customer service representatives design, build and support flow cytometers. Cytek is the product of a merger between Cytek Development Inc, a respected leader in flow cytometry products and services, and Cytoville Inc, a venture capital-backed business in advanced medical instrument technology development. Cytek Biosciences is backed by Cowin Healthcare Fund, Easy Prosperity and Fidelity Biosciences.http://www.cytekdev.com/
-
Investor, AdvisorZephyrus Biosciences 2014 - Mar 2016Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. www.zephyrusbio.comZephyrus was acquired by BioTechne in March 2016.http://www.prnewswire.com/news-releases/bio-techne-corporation-agrees-to-acquire-zephyrus-biosciences-inc-300238781.html -
Senior Program Officer, Global Health DiscoveryBill & Melinda Gates Foundation Oct 2008 - May 2012Seattle, Wa, UsShaped strategy and deployed capital in research and technology areas of central importance to the Foundation's Global Health mission, with a focus on emerging technologies such as genetically modified organisms and synthetic biology. Activities: Grants, BMGF Investment Committee member, Program-Related Investments (PRIs), Healthcare VC Roundtable leader.
-
Associate, Kauffman FellowFidelity Biosciences Sep 2006 - Sep 2008Fidelity Biosciences invests venture capital in private biopharmaceutical and medical technology companies. For more than 30 years, Fidelity Investments has been a significant presence in the venture capital and private equity industry, investing the firms own capital since 1969. During her Kauffman Fellowship at Fidelity Biosciences, Jenny focused on venture capital investment opportunities in diagnostics and life science tools. She served on the Boards of Directors of Accuri Cytometers and U.S. Genomics, and was the liaison with Fidelity's sister fund in India.
-
Vp Corporate DevelopmentU.S. Genomics Sep 2005 - Sep 2006Secured a partnership to commercialize the company's biosensor technology in the Defense and Homeland Security markets.
-
Vp Research & Development / CsoU.S. Genomics Jul 2004 - Sep 2005Oversaw the development and launch of the company's first molecular biology products, and drove seminal publications demonstrating applications of the company's technology. Managed high-caliber, multidisciplinary science and engineering team.
-
Director, Business Development / Director Of Collaborative R&DU.S. Genomics Sep 2001 - Jul 2004Defined initial markets and products, and authored the VC-backed biotech's first business plan. Established and managed relationships with life science researchers in academia and industry, ensuring the early adoption of U.S. Genomics' single molecule detection technology.
-
Engagement ManagerMckinsey & Co Sep 1998 - Sep 2001UsAdvised leading pharmaceutical and biotech companies on business strategy. Led NY/Tri-state Summer Associate program (2000).
Jenny Rooke Skills
Jenny Rooke Education Details
-
Yale UniversityGenetics -
Georgia Institute Of TechnologyPhysics
Frequently Asked Questions about Jenny Rooke
What company does Jenny Rooke work for?
Jenny Rooke works for Genoa Ventures
What is Jenny Rooke's role at the current company?
Jenny Rooke's current role is Managing Director.
What is Jenny Rooke's email address?
Jenny Rooke's email address is je****@****bio.com
What is Jenny Rooke's direct phone number?
Jenny Rooke's direct phone number is +141591*****
What schools did Jenny Rooke attend?
Jenny Rooke attended Yale University, Georgia Institute Of Technology.
What skills is Jenny Rooke known for?
Jenny Rooke has skills like Biotechnology, Venture Capital, Start Ups, Lifesciences, Life Sciences, Molecular Biology, Genomics, Business Strategy, Business Development, Strategy, Strategic Planning, Research.
Who are Jenny Rooke's colleagues?
Jenny Rooke's colleagues are Vatshal Bhanushali.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial